CTech 24/7
- Here’s how PhaseV uses AI to optimize clinical trials to speed clinical development
- “We will see a lot of mid-sized mid-market companies evaporate in the coming years”
- Cyera CEO: “We allow enterprises to move quickly with AI but to do it responsibly and securely”
- AI or die: Microsoft and investors warn startups must adapt
More stories in CTech
